Screener
CRISPR Therapeutics CRSP Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $4.57B.
The source filing: CRISPR Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:48 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204188
FAQ
- What is CRISPR Therapeutics's market capitalization?
- CRISPR Therapeutics (CRSP) reported market capitalization of $4.57B in Q1 2026.
- How has CRISPR Therapeutics's market capitalization changed year-over-year?
- CRISPR Therapeutics's market capitalization increased by 56.4% year-over-year, from $2.92B to $4.57B.
- What is the long-term trend for CRISPR Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's market capitalization has grown at a -15.7% compound annual growth rate (CAGR), from $11.72B to $5B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about CRISPR Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude